Skip to main content
NCBI home page
Postgraduate Medical Journal logoLink to Postgraduate Medical Journal
editorial
. 1991 Jul;67(789):601–605. doi: 10.1136/pgmj.67.789.601

Osteoporosis--an opportunity to prevent being missed.

A D Woolf
PMCID: PMC2399065  PMID: 1924044

Full text

PDF
601

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Barlow D. H., Brockie J. A., Rees C. M. Study of general practice consultations and menopausal problems. Oxford General Practitioners Menopause Study Group. BMJ. 1991 Feb 2;302(6771):274–276. doi: 10.1136/bmj.302.6771.274. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Bernstein D. S., Sadowsky N., Hegsted D. M., Guri C. D., Stare F. J. Prevalence of osteoporosis in high- and low-fluoride areas in North Dakota. JAMA. 1966 Oct 31;198(5):499–504. [PubMed] [Google Scholar]
  3. Block J. E., Smith R., Black D., Genant H. K. Does exercise prevent osteoporosis? JAMA. 1987 Jun 12;257(22):3115–3117. doi: 10.1001/jama.1987.03390220113033. [DOI] [PubMed] [Google Scholar]
  4. Boyce W. J., Vessey M. P. Rising incidence of fracture of the proximal femur. Lancet. 1985 Jan 19;1(8421):150–151. doi: 10.1016/s0140-6736(85)91915-4. [DOI] [PubMed] [Google Scholar]
  5. Brinton L. A., Hoover R., Fraumeni J. F., Jr Menopausal oestrogens and breast cancer risk: an expanded case-control study. Br J Cancer. 1986 Nov;54(5):825–832. doi: 10.1038/bjc.1986.246. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Chow R., Harrison J. E., Notarius C. Effect of two randomised exercise programmes on bone mass of healthy postmenopausal women. Br Med J (Clin Res Ed) 1987 Dec 5;295(6611):1441–1444. doi: 10.1136/bmj.295.6611.1441. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Christiansen C., Christensen M. S., Transbøl I. Bone mass in postmenopausal women after withdrawal of oestrogen/gestagen replacement therapy. Lancet. 1981 Feb 28;1(8218):459–461. doi: 10.1016/s0140-6736(81)91848-1. [DOI] [PubMed] [Google Scholar]
  8. Cooper C., Barker D. J., Morris J., Briggs R. S. Osteoporosis, falls, and age in fracture of the proximal femur. Br Med J (Clin Res Ed) 1987 Jul 4;295(6589):13–15. doi: 10.1136/bmj.295.6589.13. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Cummings S. R., Kelsey J. L., Nevitt M. C., O'Dowd K. J. Epidemiology of osteoporosis and osteoporotic fractures. Epidemiol Rev. 1985;7:178–208. doi: 10.1093/oxfordjournals.epirev.a036281. [DOI] [PubMed] [Google Scholar]
  10. Dalsky G. P., Stocke K. S., Ehsani A. A., Slatopolsky E., Lee W. C., Birge S. J., Jr Weight-bearing exercise training and lumbar bone mineral content in postmenopausal women. Ann Intern Med. 1988 Jun;108(6):824–828. doi: 10.7326/0003-4819-108-6-824. [DOI] [PubMed] [Google Scholar]
  11. Drinkwater B. L., Nilson K., Chesnut C. H., 3rd, Bremner W. J., Shainholtz S., Southworth M. B. Bone mineral content of amenorrheic and eumenorrheic athletes. N Engl J Med. 1984 Aug 2;311(5):277–281. doi: 10.1056/NEJM198408023110501. [DOI] [PubMed] [Google Scholar]
  12. Evans J. G., Prudham D., Wandless I. A prospective study of fractured proximal femur: incidence and outcome. Public Health. 1979 Jul;93(4):235–241. doi: 10.1016/s0033-3506(79)80036-0. [DOI] [PubMed] [Google Scholar]
  13. Geusens P., Dequeker J. Long-term effect of nandrolone decanoate, 1 alpha-hydroxyvitamin D3 or intermittent calcium infusion therapy on bone mineral content, bone remodeling and fracture rate in symptomatic osteoporosis: a double-blind controlled study. Bone Miner. 1986 Sep;1(4):347–357. [PubMed] [Google Scholar]
  14. Gärdsell P., Johnell O., Nilsson B. E. Predicting fractures in women by using forearm bone densitometry. Calcif Tissue Int. 1989 Apr;44(4):235–242. doi: 10.1007/BF02553757. [DOI] [PubMed] [Google Scholar]
  15. Harris S. S., Caspersen C. J., DeFriese G. H., Estes E. H., Jr Physical activity counseling for healthy adults as a primary preventive intervention in the clinical setting. Report for the US Preventive Services Task Force. JAMA. 1989 Jun 23;261(24):3588–3598. [PubMed] [Google Scholar]
  16. Horsman A., Gallagher J. C., Simpson M., Nordin B. E. Prospective trial of oestrogen and calcium in postmenopausal women. Br Med J. 1977 Sep 24;2(6090):789–792. doi: 10.1136/bmj.2.6090.789. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Hui S. L., Slemenda C. W., Johnston C. C., Jr Baseline measurement of bone mass predicts fracture in white women. Ann Intern Med. 1989 Sep 1;111(5):355–361. doi: 10.7326/0003-4819-111-5-355. [DOI] [PubMed] [Google Scholar]
  18. Hunt K., Vessey M. Long-term effects of postmenopausal hormone therapy. Br J Hosp Med. 1987 Nov;38(5):450-3, 456-60. [PubMed] [Google Scholar]
  19. Kanis J. A., Passmore R. Calcium supplementation of the diet--I. BMJ. 1989 Jan 21;298(6667):137–140. doi: 10.1136/bmj.298.6667.137. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Kanis J. A., Passmore R. Calcium supplementation of the diet--II. BMJ. 1989 Jan 28;298(6668):205–208. doi: 10.1136/bmj.298.6668.205. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Koppelman M. C., Kurtz D. W., Morrish K. A., Bou E., Susser J. K., Shapiro J. R., Loriaux D. L. Vertebral body bone mineral content in hyperprolactinemic women. J Clin Endocrinol Metab. 1984 Dec;59(6):1050–1053. doi: 10.1210/jcem-59-6-1050. [DOI] [PubMed] [Google Scholar]
  22. Lindsay R., Hart D. M., Aitken J. M., MacDonald E. B., Anderson J. B., Clarke A. C. Long-term prevention of postmenopausal osteoporosis by oestrogen. Evidence for an increased bone mass after delayed onset of oestrogen treatment. Lancet. 1976 May 15;1(7968):1038–1041. doi: 10.1016/s0140-6736(76)92217-0. [DOI] [PubMed] [Google Scholar]
  23. Lindsay R., Hart D. M., Forrest C., Baird C. Prevention of spinal osteoporosis in oophorectomised women. Lancet. 1980 Nov 29;2(8205):1151–1154. doi: 10.1016/s0140-6736(80)92592-1. [DOI] [PubMed] [Google Scholar]
  24. Mamelle N., Meunier P. J., Dusan R., Guillaume M., Martin J. L., Gaucher A., Prost A., Zeigler G., Netter P. Risk-benefit ratio of sodium fluoride treatment in primary vertebral osteoporosis. Lancet. 1988 Aug 13;2(8607):361–365. doi: 10.1016/s0140-6736(88)92834-6. [DOI] [PubMed] [Google Scholar]
  25. Matković V., Kostial K., Simonović I., Buzina R., Brodarec A., Nordin B. E. Bone status and fracture rates in two regions of Yugoslavia. Am J Clin Nutr. 1979 Mar;32(3):540–549. doi: 10.1093/ajcn/32.3.540. [DOI] [PubMed] [Google Scholar]
  26. Mazess R. B., Whedon G. D. Immobilization and bone. Calcif Tissue Int. 1983 May;35(3):265–267. doi: 10.1007/BF02405043. [DOI] [PubMed] [Google Scholar]
  27. Miller C. W. Survival and ambulation following hip fracture. J Bone Joint Surg Am. 1978 Oct;60(7):930–934. [PubMed] [Google Scholar]
  28. Nevitt M. C., Cummings S. R., Kidd S., Black D. Risk factors for recurrent nonsyncopal falls. A prospective study. JAMA. 1989 May 12;261(18):2663–2668. [PubMed] [Google Scholar]
  29. Overgaard K., Riis B. J., Christiansen C., Pødenphant J., Johansen J. S. Nasal calcitonin for treatment of established osteoporosis. Clin Endocrinol (Oxf) 1989 Apr;30(4):435–442. doi: 10.1111/j.1365-2265.1989.tb00443.x. [DOI] [PubMed] [Google Scholar]
  30. Paganini-Hill A., Ross R. K., Gerkins V. R., Henderson B. E., Arthur M., Mack T. M. Menopausal estrogen therapy and hip fractures. Ann Intern Med. 1981 Jul;95(1):28–31. doi: 10.7326/0003-4819-95-1-28. [DOI] [PubMed] [Google Scholar]
  31. Preger L., Steinbach H. L., Moskowitz P., Scully A. L., Goldberg M. B. Roentgenographic abnormalities in phenotypic females with gonadal dysgenesis. A comparison of chromatin positive patients and chromatin negative patients. Am J Roentgenol Radium Ther Nucl Med. 1968 Dec;104(4):899–910. doi: 10.2214/ajr.104.4.899. [DOI] [PubMed] [Google Scholar]
  32. Reeve J., Meunier P. J., Parsons J. A., Bernat M., Bijvoet O. L., Courpron P., Edouard C., Klenerman L., Neer R. M., Renier J. C. Anabolic effect of human parathyroid hormone fragment on trabecular bone in involutional osteoporosis: a multicentre trial. Br Med J. 1980 Jun 7;280(6228):1340–1344. doi: 10.1136/bmj.280.6228.1340. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Riggs B. L., Hodgson S. F., O'Fallon W. M., Chao E. Y., Wahner H. W., Muhs J. M., Cedel S. L., Melton L. J., 3rd Effect of fluoride treatment on the fracture rate in postmenopausal women with osteoporosis. N Engl J Med. 1990 Mar 22;322(12):802–809. doi: 10.1056/NEJM199003223221203. [DOI] [PubMed] [Google Scholar]
  34. Simonen O., Laitinen O. Does fluoridation of drinking-water prevent bone fragility and osteoporosis? Lancet. 1985 Aug 24;2(8452):432–434. doi: 10.1016/s0140-6736(85)92748-5. [DOI] [PubMed] [Google Scholar]
  35. Spector T. D. Use of oestrogen replacement therapy in high risk groups in the United Kingdom. BMJ. 1989 Dec 9;299(6713):1434–1435. doi: 10.1136/bmj.299.6713.1434. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Stampfer M. J., Willett W. C., Colditz G. A., Rosner B., Speizer F. E., Hennekens C. H. A prospective study of postmenopausal estrogen therapy and coronary heart disease. N Engl J Med. 1985 Oct 24;313(17):1044–1049. doi: 10.1056/NEJM198510243131703. [DOI] [PubMed] [Google Scholar]
  37. Stevenson J. C., Lees B., Devenport M., Cust M. P., Ganger K. F. Determinants of bone density in normal women: risk factors for future osteoporosis? BMJ. 1989 Apr 8;298(6678):924–928. doi: 10.1136/bmj.298.6678.924. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Storm T., Thamsborg G., Steiniche T., Genant H. K., Sørensen O. H. Effect of intermittent cyclical etidronate therapy on bone mass and fracture rate in women with postmenopausal osteoporosis. N Engl J Med. 1990 May 3;322(18):1265–1271. doi: 10.1056/NEJM199005033221803. [DOI] [PubMed] [Google Scholar]
  39. Tinetti M. E., Speechley M., Ginter S. F. Risk factors for falls among elderly persons living in the community. N Engl J Med. 1988 Dec 29;319(26):1701–1707. doi: 10.1056/NEJM198812293192604. [DOI] [PubMed] [Google Scholar]
  40. Watts N. B., Harris S. T., Genant H. K., Wasnich R. D., Miller P. D., Jackson R. D., Licata A. A., Ross P., Woodson G. C., 3rd, Yanover M. J. Intermittent cyclical etidronate treatment of postmenopausal osteoporosis. N Engl J Med. 1990 Jul 12;323(2):73–79. doi: 10.1056/NEJM199007123230201. [DOI] [PubMed] [Google Scholar]
  41. Weiss N. S., Ure C. L., Ballard J. H., Williams A. R., Daling J. R. Decreased risk of fractures of the hip and lower forearm with postmenopausal use of estrogen. N Engl J Med. 1980 Nov 20;303(21):1195–1198. doi: 10.1056/NEJM198011203032102. [DOI] [PubMed] [Google Scholar]
  42. Wolman R. L. Bone mineral density levels in elite female athletes. Ann Rheum Dis. 1990 Dec;49(12):1013–1016. doi: 10.1136/ard.49.12.1013. [DOI] [PMC free article] [PubMed] [Google Scholar]
  43. Wolman R. L., Clark P., McNally E., Harries M., Reeve J. Menstrual state and exercise as determinants of spinal trabecular bone density in female athletes. BMJ. 1990 Sep 15;301(6751):516–518. doi: 10.1136/bmj.301.6751.516. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Postgraduate Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES